Delivery Order SPE2DB25D3005-SPE2DB25FQHLS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine ER 600 mg tablets (100-count) on August 7, 2025, with a ceiling value of $12,813.16. This firm fixed price delivery order, which represents non-competitive procurement, is scheduled for completion by August 8, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded under the...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count bottles) valued at $5,628.80 under a firm fixed-price contract structure. This non-set-aside delivery order represents a child contract against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,004.97 firm fixed-price delivery order is for 100 tablets of 600 mg Oxcarbazepine extended-release medication. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-seven thousand nine hundred ninety-six dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of 600mg Oxcarbazepine, an anticonvulsant medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 31, 2023 and August 1, 2023. The prime contractor, Amerisourcebergen, will be responsible for fulfilling...
- This federal contract award is for the delivery of Oxcarbazepine 300 mg tablets (100 counts) to the Defense Logistics Agency (DLA). The $3,827.32 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of March 15, 2022 and was awarded on March 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $48,000 to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 150mg Oxcarbazepine tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 23, 2023 under the terms of the order. The Defense Logistics Agency routinely issues such requirements to established pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OXCARBAZEPINE ER 600 MG TABLET 100S, a neurological medication, with a ceiling value of $3,243.48 and a completion date of July 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-five thousand three hundred thirty dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of 150 milligram Oxcarbazepine, an anticonvulsant medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the order issued on June 27, 2023 for delivery by June 28, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the requirements...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQHLSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units, with a ceiling value of $3,449.47 and firm fixed pricing. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 1, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a continuation of the vendor's established role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/31/25 |